Nuzenio

Coronary Inflammation Technology

Coronary Inflammation Technology news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 4 latest news signals 3 publisher sources 100/100 entity strength

Latest news

New heart drug targeting inflammation falls short in clinical trial - Cardiovascular BusinessCardiovascular Business · Thu, 06 Aug 2026 20:22:24 GMTCaristo wins FDA authorization for cardiovascular risk predictor - MedTech DiveMedTech Dive · Tue, 04 Aug 2026 19:44:09 GMTCaristo Diagnostics' CaRi-Heart® Coronary Inflammation Technology Authorized by U.S. FDA - PR NewswirePR Newswire · Wed, 29 Jul 2026 14:00:00 GMTFDA authorizes first AI tech for visualizing coronary inflammation in CT scans - Cardiovascular BusinessCardiovascular Business · Wed, 29 Jul 2026 07:00:00 GMT

Timeline

Thu, 06 Aug 2026 20:22:24 GMTNew heart drug targeting inflammation falls short in clinical trial - Cardiovascular Business
Tue, 04 Aug 2026 19:44:09 GMTCaristo wins FDA authorization for cardiovascular risk predictor - MedTech Dive
Wed, 29 Jul 2026 14:00:00 GMTCaristo Diagnostics' CaRi-Heart® Coronary Inflammation Technology Authorized by U.S. FDA - PR Newswire
Wed, 29 Jul 2026 07:00:00 GMTFDA authorizes first AI tech for visualizing coronary inflammation in CT scans - Cardiovascular Business

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Coronary Inflammation Technology.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.